We use essential cookies for the site to work and optional analytics and marketing cookies. You can accept or reject them — your choice can be changed at any time. Learn more
Tratamento
Many people wonder whether Ozempic stops working after months of use. The short answer is nuanced: the medication continues working, but your body does adapt. Here's what the science actually says about long-term Ozempic efficacy and what you can do about it.
A guide to understanding how ANVISA regulates GLP-1 weight loss pens in Brazil, including approved medications, import rules, and prescription requirements.
Você já se perguntou sobre doses mais altas de tirzepatida? Entenda o que existe de verdade, quem pode se beneficiar e o que a ciência diz sobre o uso máximo desse medicamento.
Getting ready for your first GLP-1 consultation? Here's everything you need to gather before your appointment to make the most of your time with the doctor.
Brazilian patients watching semaglutide developments internationally may find the Canadian approval of a Sandoz biosimilar relevant to their options. Here's what we know and what it could mean for access.
Curious about stopping a weight loss pen suddenly? Learn about the biological timeline, appetite changes, and weight regain risks after discontinuing GLP-1 medications.
Many people wonder if natural alternatives can match Ozempic for weight loss. Here's what science actually says about the difference between medications and supplements.
Discover how Mounjaro's dual-action approach targeting both GIP and GLP-1 receptors may help promote weight loss differently than single-receptor medications.
Wondering how to maintain weight after stopping your weight loss medication? Here's what science tells us about preventing regain when you come off GLP-1 drugs.
Discover the real reasons Ozempic prices in Brazil exceed those in other countries. From ANVISA registration fees to import taxes and supply chain markups, we break down every layer of the cost structure affecting GLP-1 medication accessibility.
